Jiangsu wuzhong(SH:600200) 2 1 Shi Ji Jing Ji Bao Dao·2025-07-14 09:48Group 1 - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Wuzhong, stock code: 600200) is facing mandatory delisting due to significant violations, including financial fraud for four consecutive years [1] - The company received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) detailing three major violations: concealing the actual controller, inflating performance, and hiding fund occupation [1] - The actual controller of *ST Wuzhong was misrepresented in annual reports from 2018 to 2023, with the real controller being Qian Qunshan, who was not disclosed [1] Group 2 - Starting from July 14, the company's stock will be subject to additional delisting risk warnings by the Shanghai Stock Exchange due to multiple risk alerts [2] - The company also faces other risk warnings as its 2024 annual financial report received an "unable to express an opinion" from the auditing firm, indicating issues with internal controls [2] Group 3 - Qian Qunshan, the company's chairman, has been fined 15 million yuan and banned from the securities market for 10 years for concealing the actual controller's identity and signing false annual reports [3] - The severe penalties reflect the regulatory authority's commitment to combating financial fraud and maintaining market order, serving as a warning for compliance in information disclosure [3]